{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:28:36Z","timestamp":1774679316010,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ctro.2026.101130","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:40:31Z","timestamp":1771375231000},"page":"101130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inguinal CTV contouring in anal cancer: comparative validation of inguinal lymph nodes contouring guidelines and implications for consensus"],"prefix":"10.1016","volume":"58","author":[{"given":"Viola","family":"De Luca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Manfrida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Barogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"De Giacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella Michela","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Fionda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Bertolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuditta","family":"Chiloiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Autorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Dinapoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"L.Hallemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison E.","family":"Garda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Antonietta","family":"Gambacorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101130_b0005","doi-asserted-by":"crossref","unstructured":"H. Bartelink et al., \u201cConcomitant Radiotherapy and Chemotherapy Is Superior to Radiotherapy Alone in the Treatment of Locally Advanced Anal Cancer: Results of a Phase III Randomized Trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups,\u201d 1997.","DOI":"10.1200\/JCO.1997.15.5.2040"},{"key":"10.1016\/j.ctro.2026.101130_b0010","doi-asserted-by":"crossref","unstructured":"M. Flam et al., \u201cRole of Mitomycin in Combination With Fluorouracil and Radiotherapy, and of Salvage Chemoradiation in the Definitive Nonsurgical Treatment of Epidermoid Carcinoma of the Anal Canal: Results of a Phase III Randomized Intergroup Study,\u201d 1996.","DOI":"10.1200\/JCO.1996.14.9.2527"},{"issue":"35","key":"10.1016\/j.ctro.2026.101130_b0015","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","article-title":"Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin","volume":"30","author":"Gunderson","year":"2012","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ctro.2026.101130_b0020","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","article-title":"Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial","volume":"30","author":"Peiffert","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2026.101130_b0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","article-title":"Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2\u00d72 factorial trial","volume":"14","author":"James","year":"2013","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctro.2026.101130_b0030","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.annonc.2020.06.012","article-title":"Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trial","volume":"31","author":"Glynne-Jones","year":"2020","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101130_b0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/RLU.0000000000000942","article-title":"Lymphatic Path of the Inguinal Lymph Node Metastases in Anorectal Cancer: the Springbok Pattern","volume":"40","author":"Gemenetzis","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ctro.2026.101130_b0040","doi-asserted-by":"crossref","unstructured":"J.-P. Gerard et al., \u201cManagement of Inguinal Lymph Node Metastases in Patients with Carcinoma of the Anal Canal Experience in a Series of 270 Patients Treated in Lyon and Review of the Literature,\u201d 2001.","DOI":"10.1002\/1097-0142(20010701)92:1<77::AID-CNCR1294>3.0.CO;2-P"},{"issue":"5","key":"10.1016\/j.ctro.2026.101130_b0045","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ijrobp.2011.12.058","article-title":"Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer","volume":"83","author":"Ng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2026.101130_b0050","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: a Radiation Therapy Oncology Group Consensus Panel Contouring Atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101130_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2025.02.001","article-title":"Radiation Therapy for Anal Squamous Cell Carcinoma: an ASTRO Clinical Practice Guideline","author":"Feng","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101130_b0060","unstructured":"\u201cClinical Oncology National guidance for volumetric-modulated arc therapy (VMAT) or intensity-modulated radiotherapy (IMRT) in anal cancer,\u201d 2024."},{"issue":"1","key":"10.1016\/j.ctro.2026.101130_b0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2010.10.005","article-title":"T1-2 anal carcinoma requires elective inguinal radiation treatment - the results of Trans Tasman Radiation Oncology Group study TROG 99.02","volume":"98","author":"Matthews","year":"2011","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2026.101130_b0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2013.03.008","article-title":"Elective inguinal node irradiation in early-stage T2N0 anal cancer: Prognostic impact on locoregional control","volume":"87","author":"Zilli","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2026.101130_b0075","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2009.09.029","article-title":"Squamous cell carcinoma of the anal canal: patterns and predictors of failure and implications for intensity-modulated radiation treatment planning","volume":"78","author":"Wright","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2026.101130_b0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ijrobp.2011.07.007","article-title":"Twenty-five-year experience with radical chemoradiation for anal cancer","volume":"83","author":"Tomaszewski","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctro.2026.101130_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ctro.2026.101130_b0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/0300891618811273","article-title":"Chemoradiation in female patients with anal cancer: Patient-reported outcome of acute and chronic side effects","volume":"105","author":"Koerber","year":"2019","journal-title":"Tumori"},{"issue":"2","key":"10.1016\/j.ctro.2026.101130_b0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2005.02.030","article-title":"Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome","volume":"63","author":"Milano","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101130_b0100","doi-asserted-by":"crossref","unstructured":"L. Caravatta et al., \u201cRadiotherapy with intensity-modulated (Imrt) techniques in the treatment of anal carcinoma (rainstorm): A multicenter study on behalf of airo (Italian association of radiotherapy and clinical oncology) gastrointestinal study group,\u201d Cancers (Basel), vol. 13, no. 8, Apr. 2021, doi: 10.3390\/cancers13081902.","DOI":"10.3390\/cancers13081902"},{"issue":"3","key":"10.1016\/j.ctro.2026.101130_b0105","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.21873\/invivo.13570","article-title":"High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience","volume":"38","author":"Manfrida","year":"2024","journal-title":"In Vivo (brooklyn)"},{"key":"10.1016\/j.ctro.2026.101130_b0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.radonc.2020.05.018","article-title":"Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation","volume":"149","author":"Garda","year":"2020","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101130_b0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ejrad.2005.12.039","article-title":"Ultrasound of superficial lymph nodes","volume":"58","author":"Esen","year":"2006","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.ctro.2026.101130_b0120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.prro.2011.12.005","article-title":"Contouring inguinal and femoral nodes; how much margin is needed around the vessels?","volume":"2","author":"Kim","year":"2012","journal-title":"Pract Radiat Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101130_b0125","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2021.06.027","article-title":"Recommendations and Clinical Validation of Inguinal Clinical Target volume Delineation in Penile Cancer","volume":"111","author":"Mittal","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101130_b0130","doi-asserted-by":"crossref","unstructured":"L. G. Keenan, K. Rock, A. Azmi, O. Salib, C. Gillham, and McArdle Orla, \u201cAn atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines,\u201d Radiother Oncol, vol. 3, no. 127, pp. 417\u2013422, Jun. 2018.","DOI":"10.1016\/j.radonc.2018.02.013"},{"issue":"1","key":"10.1016\/j.ctro.2026.101130_b0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cam4.4418","article-title":"A modified delineation method of para-aortic nodal clinical target volume in patients with locally advanced cervical cancer","volume":"11","author":"Wang","year":"2022","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ctro.2026.101130_b0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s00066-020-01587-y","article-title":"Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer","volume":"196","author":"Dapper","year":"2020","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"10.1016\/j.ctro.2026.101130_b0145","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.clon.2016.10.005","article-title":"Initial results from the Royal College of Radiologists\u2019 UK National Audit of Anal Cancer Radiotherapy 2015","volume":"29","author":"Muirhead","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101130_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109634","article-title":"Inguinal nodal clinical target volume delineation based on analysis of anatomical locations of normal and metastatic lymph nodes in pelvic malignant tumors","volume":"183","author":"Chang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101130_b0155","doi-asserted-by":"crossref","unstructured":"H. Dapper et al., \u201cHave we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines,\u201d BMC Cancer, vol. 19, no. 1, Jul. 2019, doi: 10.1186\/s12885-019-5970-0.","DOI":"10.1186\/s12885-019-5970-0"},{"issue":"5","key":"10.1016\/j.ctro.2026.101130_b0160","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.ijrobp.2005.05.062","article-title":"Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy","volume":"63","author":"Taylor","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101130_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.655322","article-title":"FDG-PET\/CT in the Radiotherapy Treatment Planning of locally Advanced Anal Cancer: a Monoinstitutional Experience","volume":"11","author":"Di Carlo","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2026.101130_b0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-109655","article-title":"Personalising anal cancer radiotherapy dose (PLATO): protocol for a multicentre integrated platform trial","volume":"15","author":"Frood","year":"2025","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.ctro.2026.101130_b0175","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1186\/s12885-024-13015-w","article-title":"Investigation of the distribution of inguinal lymph nodes and delineation of the inguinal clinical target volume using 18F-FDG PET\/CT","volume":"24","author":"Han","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ctro.2026.101130_b0180","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.prro.2022.01.015","article-title":"ECOG-ACRIN Guideline for Contouring and Treatment of Early Stage Anal Cancer using IMRT\/IGRT","volume":"124","author":"Damico","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ctro.2026.101130_b0185","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/0284186X.2023.2240490","article-title":"Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer","volume":"62","author":"Nilsson","year":"2023","journal-title":"Acta Oncol (madr)"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T04:25:57Z","timestamp":1774671957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082600025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"alternative-id":["S240563082600025X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101130","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inguinal CTV contouring in anal cancer: comparative validation of inguinal lymph nodes contouring guidelines and implications for consensus","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101130"}}